Research

Life Sciences & Biotechnology

Title :

A randomized, Double-blind, Placebo and Active controlled, Multicenter, Phase 3 Study to Access the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severely Active Rheumatoid Arthritis who Are Naive to MTX Therapy

Area of research :

Life Sciences & Biotechnology, Medical Sciences

Focus area :

Orthopedics

Principal Investigator :

Dr Uma Kumar, Professor & Head, All India Institute of Medical Sciences (AIIMS), New Delhi

Timeline Start Year :

2018

Timeline End Year :

2022

Contact info :

Details

Total Budget (INR):

10,00,000

Organizations involved